Page last updated: 2024-11-02

pentoxifylline and Hepatitis

pentoxifylline has been researched along with Hepatitis in 5 studies

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Feeding mice a methionine choline deficient (MCD) diet serves as a nutritional model of non-alcoholic steatohepatitis (NASH)."7.72Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. ( Green, RM; Koppe, SW; Malladi, P; Sahai, A; Whitington, PF, 2004)
"5 times) were given pentoxyfylline at a dosage of 400 mg t."6.73Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. ( Malhotra, V; Sakhuja, P; Sarin, SK; Satapathy, SK; Sharma, BC, 2007)
"The evaluation of the efficacy of ursodeoxycholic acid (UDCA), pentoxifylline, losartan, and atorvastatin in non-alcoholic steatohepatitis (NASH) treatment."5.12Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. ( Georgescu, EF; Georgescu, M, 2007)
"Feeding mice a methionine choline deficient (MCD) diet serves as a nutritional model of non-alcoholic steatohepatitis (NASH)."3.72Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. ( Green, RM; Koppe, SW; Malladi, P; Sahai, A; Whitington, PF, 2004)
"5 times) were given pentoxyfylline at a dosage of 400 mg t."2.73Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. ( Malhotra, V; Sakhuja, P; Sarin, SK; Satapathy, SK; Sharma, BC, 2007)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koppe, SW1
Sahai, A1
Malladi, P1
Whitington, PF1
Green, RM1
Georgescu, EF1
Georgescu, M1
Chitturi, S1
Farrell, GC1
Satapathy, SK1
Sakhuja, P1
Malhotra, V1
Sharma, BC1
Sarin, SK1
Koppenhagen, K1
Wenig, HG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH)[NCT04193982]Phase 3250 participants (Anticipated)Interventional2021-01-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

3 trials available for pentoxifylline and Hepatitis

ArticleYear
Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
    Journal of gastrointestinal and liver diseases : JGLD, 2007, Volume: 16, Issue:1

    Topics: Adult; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholagogues and Choleretics;

2007
Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:5

    Topics: Administration, Oral; Adult; Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Female;

2007
[The effect of pentoxifylline on liver perfusion: a comparative study in patients with liver diseases and in normal subjects, using 198Au-colloid-scintigraphy (author's transl)].
    Medizinische Klinik, 1979, Aug-31, Volume: 74, Issue:35

    Topics: Adult; Aged; Chronic Disease; Female; Hepatitis; Humans; Liver; Liver Circulation; Liver Cirrhosis;

1979

Other Studies

2 other studies available for pentoxifylline and Hepatitis

ArticleYear
Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Journal of hepatology, 2004, Volume: 41, Issue:4

    Topics: Alanine Transaminase; Animals; Choline Deficiency; Deficiency Diseases; Diet; Disease Progression; F

2004
TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:5

    Topics: Animals; Fatty Liver; Hepatitis; Humans; Liver; Liver Cirrhosis; Necrosis; Pentoxifylline; Protectiv

2007